Tags Posts tagged with "Cannabis"

Cannabis

0 948
VPR Brands

VPR Brands, LP (VPRB) Files Annual Financial Statement (10K) After Market Close On Monday 4-17-2017

Click Here: VPRB10K For Full 10K Filing

About VPR Brands LP:

VPR Brands is a technology company; whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about VPR Brands, please visit the company on the web at www.vprbrands.com.


Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 90 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $45,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. We may buy or sell additional shares of (VPRB) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1915

Proposal Aims For Medical Marijuana Legalization In North Carolina

A recent proposal aims to legalize medical marijuana in North Carolina. The bill lays out the development of a medical marijuana supply system and aims to create a program administered by the UNC system called the North Carolina Cannabis Research Program. The program would conduct studies to determine the safety and efficacy of cannabis as medical treatment and then develop guidelines for the appropriate physician administration and patient use of medical cannabis.


Click Here Now To Read Full Article


Industrial Hemp Project At The University Of Minnesota

University of Minnesota students may do double-takes this summer if they spot what looks like marijuana plants growing on the agricultural testing fields at the St. Paul campus. However, the dark green foliage with jagged leaves will actually be industrial hemp, a close look-alike and cousin to marijuana that’s useless for getting high but potentially valuable for certain foods, cosmetics, and oil.


Click Here Now To Read Full Article


Texas One Step Closer To Decriminalizing Marijuana

Texas is one step closer to eradicating the criminal penalties associated with minor marijuana possession. The House Criminal Jurisprudence Committee recently put its seal of approval on a proposal (House Bill 81) that would allow police all over the state to simply slap those people caught in possession of up to an ounce of weed with a small fine instead of dragging them to jail. The state currently deems this offense a Class B misdemeanor, which carries the potential for marijuana offenders to serve up to six months behind bars.


Click Here Now To Read Full Article


0 1398

$VPRB Brands HONEYSTICK and Gold Nugget Extracts Will Be Teaming Up

VPR Brands, LP ( OTC PINK : VPRB ) and Gold Nugget extracts will be teaming up for the High Times Cannabis Cup So-Cal April 21-23. Gold Nugget Extracts will officially be powered by our flagship vaporizer the HONEYSTICK. Our Vaporizers will be paired with Gold Nugget top shelf extracts in various categories under jointly branded units. The VPR Brands HONEYSTICK team will also be sharing sales and marketing booth with Gold Nugget Extracts at the event targeting both vendors & retail consumers.


Click Here Now To Read Full PR


$MCIG Grow Contractors Launches Greenhouse Website Portal


Grow Contractors, Inc., (GC) a wholly owned subsidiary of mCig, Inc. ( OTCQB : MCIG ), a diversified company servicing the legal Cannabis, Hemp, and CBD markets, launched its new greenhouse website at www.growcontractors.org/greenhouses/

Rob Kressa, GC’s CEO, stated, “The new open disclosure standard for the greenhouse selling portal is just the first step in our progression to becoming the nation’s largest greenhouse supplier in the cannabis grow and herbal farming markets. Since we announced our exclusive agreement with Sangreen for distribution of greenhouses at half the cost of the current market price, we have spent the past few months perfecting the design and supply lines.”


Click Here Now To Read Full PR


$ADVT Gets Largest Order to Date from SpeedWeed

ADVANTIS CORPORATION ( OTC PINK : ADVT ) announced today that SpeedWeed, California’s largest Collective, placed what has become for Advantis, their largest order to date. Advantis further announced, among other positive news, that their 1st quarter revenues are up 300% from the previous quarter. Advantis also announced that they received their first order from Arsenal, a large collective in San Diego. According to Advantis CEO Christopher Swartz, “This new technically-driven collective has placed its initial order and will begin carrying our entire product line next week.”


Click Here Now To Read Full PR


Virginia Moves Forward In Marijuana Reform, Decriminalizing CBD

Two marijuana reform bills were recently signed by Virginia Governor Terry McAuliffe (D), ending the state’s automatic six-month driver’s license suspension for first time possession offenders and allowing the production of CBD oil. This may look like a couple drops in a raging storm of national decriminalization, but NORML Executive Director, Erik Altieri, said it’s a huge accomplishment.


Click Here Now To Read Full Article


Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 90 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $45,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. We may buy or sell additional shares of (VPRB) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Unsubscribe | To contact us please reply to this email | PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1214


$UBQU Set to Capitalize Retired NFL Players And Celebrity Endorsements Of CBD



Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its subsidiary HempLife Today™ is set to capitalize on recent endorsements of CBD by some retired NFL players and many notable celebrities. The company believes that because of this additional publicity, CBD is becoming known to a larger segment of the population, and because of the positioning of HempLife Today™ and the CannazALL™ brand of CBD products derived from Hemp, sales of CannazALL™ products will increase as well.

 


Click Here Now To Read Full PR


Can CBDs Found in Marijuana Be an Alternative Treatment to Diabetes


The combination of CBD and THCV (tetrahydrocannabivarin) looks to have significant therapeutic potential in the treatment of Type 2 diabetes. Research concerning THCV and Type 2 diabetes has been making scientific news for at least three years. THCV is what chemists call the propyl variant of THC. While THCV is psychoactive, it’s a shorter, more intense high than THC. THC is a few hours at the amusement park; THCV is an hour on the roller coaster.


Click Here Now To Read Full Article


Marijuana Proposal In California May Restrict Local Police From Cracking Down

Lawmakers in California have taken a page from laws establishing sanctuary cities for immigrants to create a bill aimed at protecting marijuana from a federal restriction. Similar to laws defending undocumented immigrants, the recently introduced Assembly Bill 1578 would bar cooperation by police in the state with federal authorities seeking to bust marijuana growers and sellers operating legally under California law.


Click Here Now To Read Full Article


Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 1397

$RQHTF Corporate Update

Reliq Health Technologies Inc. (TSX VENTURE:RHT)(RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to provide the following corporate update to current and future shareholders surrounding the recent developments at the Company.


Click Here Now To Read Full PR


$ADVT Builds Client Base, Adds Premier Orange County Cooperative


ADVANTIS CORPORATION ( OTC PINK : ADVT ) has added Seaweeds of California, considered to be the Orange County standard for medical marijuana delivery services, to its growing list of client relationships. The southern California cooperative has agreed to provide its membership with access to the entire line of products that Advantis represents.


Click Here Now To Read Full PR


Biotech Cannabis Stocks Continue to Soar

Biotech companies focused on developing and commercializing cannabis-based treatments continue to be one of the hottest places to invest and these companies continue to run higher.

 


Click Here Now To Read Full Article


 















 

Pursuant to an agreement between us and Reliq Health Technologies, Inc. we have been hired for a period of 30 days to publicly disseminate information about (RQHTF) including on the Website and other media including Facebook and Twitter. We are being paid $75,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (RQHTF), which we purchased in the open market. We plan to sell the “ZERO” shares of (RQHTF) that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of (RQHTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 6146

The cannabis industry is the fast growing and most rapidly changing industry in the world. The high growth nature of the cannabis industry offers investors a lot of opportunities, however, many of such opportunities are not sound.

The last week has been huge for the global cannabis industry and the market is already seeing positive developments after Canada announced plans to legalize recreational cannabis by July 1, 2018.

Yesterday, one of the world’s largest exchange-traded-fund (ETF) companies announces plans to list the first North American focused cannabis ETF on the Toronto Stock Exchange.

Horizons ETFs Management Canada filed its final prospectus to launch the Horizons Medical Marijuana Life Sciences ETF and the TSX approved the units to be listed and traded on April 5th under the ticker symbol HMMJ.

HMMJ will be the first ETF to offer direct exposure to North American-listed stocks levered to the medical cannabis bioengineering and production. HMMJ is an index (or passively managed) ETF, designed to provide exposure to a basket of North American publicly traded companies with significant business activities in the cannabis industry.

The index is designed to be a liquid and investable index of equity securities of publicly listed life sciences companies, and other firms, with business activities in the marijuana industry.
The index selects from a current universe of publicly-listed North American companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bio-products and other ancillary businesses to the cannabis industry.

The index will only include stocks that meet minimum asset and liquidity thresholds. The index is rebalanced quarterly on a market-capitalization basis, and capped so that no single stock can exceed 10% of the portfolio’s weight when rebalanced.

0 1809
marijuana

$UBQU Premieres New 24 Hour Interactive Customer Support Phone System

 

Ubiquitech Software Corp. ( OTC PINK : UBQU ), through its operating subsidiary HempLife Today™, is announcing the development and implementation of its new IVR (Interactive Voice Response), 24 hour toll-free customer support phone system, developed to improve customer support, customer satisfaction, and increase sales volume.

This new IVR system was developed using one of the most technologically advanced software applications in the industry, and will help the Company to better serve its daily increase of customers for its growing line of CannazALL™ CBD products derived from Hemp, by offering an easier way to learn more about the Company, the products, and to better speak to a specialist who can assist in taking an order.


Click Here Now To Read Full PR


7 Cannabis Company Developments to Highlight

This week was a busy week for cannabis stocks and this is important as it follows a couple rough weeks of trading. Some of the important develops we think investors should take note of, include…[continue reading]


Click Here Now To Read Full Article


#ICYMI: Will This Marijuana Stock See a Record Setting Year in 2017?

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU). Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year. What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.


Click Here Now To Read Full Article


 

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 5679
Marijuana Stocks

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage.  Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.

InMed Pharmaceuticals (IMLFF) is a Vancouver-based pre-clinical trial Cannabis-Biotech company that has not only developed a proprietary cannabinoid manufacturing system yet in the process created a highly sought after database, which has mapped the different compounds of cannabinoids to the various diseases that it can address.

This cannabinoid database was designed by (IMLFF) to assist them in their investigative studies and has currently become a core asset as other Cannabis Biotech companies have come knocking on their door willing to offer a hefty sum for this information. Most medical marijuana processors are using THC and CBD because they are easy to extract in large quantities, however there are more than 90 diverse cannabinoid structures that (IMLFF) has plugged into its system. The bioinformatics algorithm has taken those different compounds and screens them against approved drugs, diseases and genetic properties of diseases. It then selects specific cannabinoids that might help regulate that particular disease.

InMed Pharmaceuticals (IMLFF) has created this database “tool” & is saving time and money in the drug research process. It has already helped (IMLFF) to identify two treatments for rare diseases. One for a rare children’s skin disease called epidermolysis bullosa (EB) that has no approved treatments and the other for glaucoma. Chief Executive Officer Eric Adams said, “It’s a very devastating disease and we found out in early testing that this set of cannabinoids treat the major symptoms of this disease giving them a tremendous amount of relief, but it may also reverse the disease, which is something no one has really talked about before.”

Startup Cannabis-Biotechs like InMed Pharmaceuticals (IMLFF) will continue to grow as Marijuana Stocks / Sector continues to evolve into mainstream markets.

0 2637
marijuana_glaucoma

Research has shown that cannabinoids can alleviate glaucoma-related symptoms because they lower the intraocular pressure (IOP) and have neuroprotective actions. For example, in 1971, one of the first studies of its kind found ingestion of cannabis lowers IOP by 25 to 30%. Despite the findings from early research, very few ophthalmologists support the use of medical cannabis in patients with early to mid-stage glaucoma. The main issue ophthalmologists have with marijuana is that the potential adverse effects, particularly smoking cannabis, outweigh the short term benefits. For example, smoking can lead to unstable intraocular pressure, which heightens the risk of permanent vision loss.

Additionally, because its therapeutic effects on glaucoma are short-term, patients would have to consume marijuana frequently; once every three to four hours. Physicians claim that because glaucoma needs to be treated 24 hours per day, patients would need to consume marijuana six to eight times over the course of a day to achieve consistently decreased IOP levels. Such frequency is difficult to maintain and could heighten the risk of developing a marijuana use disorder. However, when it comes to late stage glaucoma, ophthalmologists are more inclined to embrace cannabis as a treatment. At the end stages of glaucoma, it is less about directly targeting the glaucoma and more about alleviating the accompanying symptoms.

Ophthalmologist Andrew Bainnson, MD stated, “We’ve known for some time that medical marijuana is very effective for treating nausea and pain, but not so much for glaucoma. However, there are some patients with end stage pain and nausea who may benefit [from medical marijuana], but not from the glaucoma point of view.” The body’s own internal cannabinoid system, called the endocannabinoid system (ECS), is one of our most important physiological systems. Nearly every aspect of our health including: inflammation, immune response, neuroprotection, pain modulation, are all dependent on the ECS. Given the vital role of the ECS, particularly in neuroprotection and inflammation, many scientists believe the development of cannabinoid-based medications may be useful in treating glaucoma.

1 3374

Cannabis shops and manufacturers have increasing concerns that the Trump Administration will enforce federal laws that restrict farming and selling the drug. This will reverse the president’s stance during his campaign and potentially overturn what has become a $7 billion industry. The worry was provoked by comments from White House spokesman Sean Spicer recently that the government would most likely boost its enforcement of drug laws.

Attorney General Jeff Sessions stated that he is “dubious” about the benefits of marijuana. He said, “Marijuana is against federal law, and that applies in states where they may have repealed their own anti-marijuana laws. So yes, we will enforce law in an appropriate way nationwide. It’s not possible for the federal government, of course, to take over everything the local police used to do in a state that’s legalized it. And I’m not in favor of legalization of marijuana. I think it’s a more dangerous drug than a lot of people realize.”

The comments have sparked worry with Chuck Smith, co-founder of Dixie Brands, a Denver-based company that manufactures topicals and edibles infused with THC, the active ingredient in cannabis. He founded the company in 2010 and now employs more than 100 people across Arizona, Colorado, California, and Nevada. Smith stated, “My concern right now for both the company and industry is just uncertainty. It’s hard to build an industry or a company when you don’t have clarity.”

The administration’s statements affected shares of Innovative Industrial Properties, which invests in cannabis-growing facilities and is one of the few publicly traded cannabis companies. Its stock price plummeted on the day of Spicer’s press conference and are down more than 13% since then. However, two other marijuana stocks, GW Pharmaceuticals and Cara Therapeutics, seem to have not been affected by the news.

Eight states now allow the use of cannabis recreationally, while more than two dozen states have legalized it for medical purposes. Twenty-one states have decriminalized cannabis. A recent Quinnipiac Poll found 71% of voters think the government should not restrict federal drug laws in states where marijuana is legal. Increasing acceptance has led to an jump in the market for cannabis in North America, with sales rising 34% to nearly $7 billion in 2016, according to Arcview Market Research. By 2021, the industry is likely to climb close to $22 billion.

Companies like Dixie Brands are charging that hike. The privately held company would not disclose current numbers, but in 2014 it was valued at $40 million. Smith said, “It’s hard for us to kind of go backwards. President Trump said he was going to allow this to be a state’s rights issue. We took him at his word.” Trump has sent mixed messages on cannabis. In the 1990s, he called for legalizing all drugs. On the campaign trail, he reiterated his support for medical cannabis and his deference to states to pass their own laws regulating the drug.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements